Actualités Merck - MRK

Les meilleurs offres pour accéder les cours en temps réel en illimité
Trader Abonnement Mensuel Seulement ~~34,09 €~~
Trade Alert US Abonnement Mensuel Seulement ~~52,79 €~~
Expert Abonnement Mensuel Seulement ~~92,39 €~~
Prix hors taxes

Nom Action	Symbole Action	Marché	Type	ISIN	Description Action
Merck	MRK	NYSE	Action ordinaire

	Variation Action	Variation Action%	Cours Dernier	Plus Haut	Plus Bas	Ouverture	Clôture Veille	Dernier échange
	0,88	1,04%	85,45	86,03	84,74	84,97	84,57	19:25:30

plus d'informations sur les cotations »

Actualités Recentes

Date	Heure	Source	Titre
20/6/2019	21:25	EDGAR	Annual Report of Employee Stock Plans (11-k)
20/6/2019	21:23	EDGAR	Annual Report of Employee Stock Plans (11-k)
20/6/2019	21:22	EDGAR	Annual Report of Employee Stock Plans (11-k)
20/6/2019	12:45	BW	Merck Hosts 2019 Investor Day Outlining Bus. Momentum,..
20/6/2019	09:02	DJN	Merck Seeks Deals As It Expands Its Cancer Treatments -- WSJ
19/6/2019	12:45	BW	AstraZeneca & Merck’s LYNPARZA® (olaparib) Approved in Japan..
19/6/2019	12:37	DJFR	Merck cherche de nouvelles cibles d'acquisition - sources
19/6/2019	11:59	DJN	Merck Seeks More Deals
18/6/2019	12:45	BW	FDA Approves Merck’s KEYTRUDA® (pembrolizumab) as..
18/6/2019	12:30	BW	LYNPARZA® (olaparib) Approved in the EU for Use as..
17/6/2019	20:36	DJFR	BOURSE: La dernière acquisition de Pfizer dope les cours..
15/6/2019	09:02	DJN	Drug Firms Sue Over Ad Rule -- WSJ
15/6/2019	00:27	DJN	Drugmakers Sue to Block Federal Rule Requiring Drug Prices..
13/6/2019	14:05	PRNUS	IBM, KPMG, Merck and Walmart to collaborate as part of FDA's..
11/6/2019	12:45	BW	FDA Approves Two New Indications for Merck’s KEYTRUDA®..
10/6/2019	14:19	DJFR	Merck va acquérir Tilos Therapeutics pour un montant allant..
10/6/2019	13:37	DJN	Merck to Buy Tilos Therapeutics for Up to $773 Million
10/6/2019	12:45	BW	Merck to Acquire Tilos Therapeutics
04/6/2019	23:22	EDGAR	Statement of Changes in Beneficial Ownership (4)
04/6/2019	23:21	EDGAR	Statement of Changes in Beneficial Ownership (4)
04/6/2019	23:21	EDGAR	Statement of Changes in Beneficial Ownership (4)
04/6/2019	23:21	EDGAR	Statement of Changes in Beneficial Ownership (4)
04/6/2019	23:20	EDGAR	Statement of Changes in Beneficial Ownership (4)
04/6/2019	23:20	EDGAR	Statement of Changes in Beneficial Ownership (4)
04/6/2019	23:20	EDGAR	Statement of Changes in Beneficial Ownership (4)
04/6/2019	23:20	EDGAR	Statement of Changes in Beneficial Ownership (4)
04/6/2019	23:19	EDGAR	Statement of Changes in Beneficial Ownership (4)
04/6/2019	23:19	EDGAR	Statement of Changes in Beneficial Ownership (4)
04/6/2019	23:19	EDGAR	Statement of Changes in Beneficial Ownership (4)
03/6/2019	22:55	BW	FDA Approves Merck’s ZERBAXA® (ceftolozane & tazobactam) 3g..
03/6/2019	22:15	BW	LYNPARZA® (olaparib) Phase 3 SOLO3 Trial Demonstrated a 72%..
03/6/2019	08:48	DJN	AstraZeneca Lynparza Trial Results 'Unprecedented'
02/6/2019	13:30	BW	LYNPARZA® (olaparib) First-Line Maintenance Therapy Nearly..
01/6/2019	13:30	BW	Five-Year Survival Data for Merck’s KEYTRUDA®..
31/5/2019	16:56	EDGAR	Current Report Filing (8-k)
31/5/2019	12:45	BW	Merck’s KEYTRUDA® (pembrolizumab) Demonstrates Improved..
29/5/2019	20:30	DJN	Johnson & Johnson Weighs on Pharmaceutical ETFs
28/5/2019	22:05	BW	Merck Announces Third-Quarter 2019 Dividend
23/5/2019	16:44	EDGAR	Specialized Disclosure Report (sd)
22/5/2019	14:00	BW	Merck Foundation Announces Grant to American Cancer Society..
21/5/2019	15:46	DJN	Merck to Buy Cancer Drug Maker Peloton Therapeutics -- 2nd..
21/5/2019	14:23	DJN	Merck to Buy Cancer Drug Maker Peloton Therapeutics --..
21/5/2019	14:00	DJN	Merck to Buy Peloton Therapeutics
21/5/2019	13:57	DJFR	Merck rachète Peloton Therapeutics pour un montant pouvant..
21/5/2019	12:45	BW	Merck to Acquire Peloton Therapeutics, Bolstering Oncology..
21/5/2019	00:51	DJN	Court Rules Judge, not Jury, Should Rule on Merck Fosamax..
20/5/2019	23:49	DJFR	Cancer: nouveaux résultats cliniques décevants pour le..
20/5/2019	23:24	DJN	Merck Says Keytruda Didn't Meet Primary Endpoint in..
20/5/2019	22:30	BW	Merck Provides Update on Phase 3 KEYNOTE-119 Study of..
20/5/2019	20:20	DJN	Supreme Court Asks Lower Court to Reconsider Merck Ruling..

Voir d'autres actualités liées à cette action »

Actualités Merck - MRK

Actualités Recentes

Intraday

Historiques